Fidelity Investments’s ARS Pharmaceuticals SPRY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.75M Sell
342,042
-56,917
-14% -$545K ﹤0.01% 2532
2025
Q4
$4.65M Sell
398,959
-343,549
-46% -$3.34M ﹤0.01% 2311
2025
Q3
$7.46M Sell
742,508
-824,502
-53% -$11.8M ﹤0.01% 2106
2025
Q2
$27.3M Buy
1,567,010
+576,150
+58% +$8.31M ﹤0.01% 1591
2025
Q1
$12.5M Sell
990,860
-111,365
-10% -$1.34M ﹤0.01% 1843
2024
Q4
$11.6M Buy
1,102,225
+15,910
+1% +$223K ﹤0.01% 1889
2024
Q3
$15.8M Buy
1,086,315
+997
+0.1% +$11.9K ﹤0.01% 1791
2024
Q2
$9.24M Buy
1,085,318
+396
+0% +$3.51K ﹤0.01% 1884
2024
Q1
$11.1M Sell
1,084,922
-117,393
-10% -$875K ﹤0.01% 1837
2023
Q4
$6.59M Sell
1,202,315
-105,025
-8% -$460K ﹤0.01% 1975
2023
Q3
$4.94M Sell
1,307,340
-3,357,438
-72% -$22M ﹤0.01% 2049
2023
Q2
$31.3M Sell
4,664,778
-423,475
-8% -$2.83M ﹤0.01% 1454
2023
Q1
$33.1M Sell
5,088,253
-281,109
-5% -$2.16M ﹤0.01% 1409
2022
Q4
$45.8M Buy
5,369,362
+605,813
+13% +$3.93M ﹤0.01% 1287
2022
Q3
$25.2M Buy
4,763,549
+1,045,097
+28% +$5.15M ﹤0.01% 1537
2022
Q2
$15.8M Sell
3,718,452
-74,720
-2% -$261K ﹤0.01% 1754
2022
Q1
$13.3M Buy
3,793,172
+39,435
+1% +$172K ﹤0.01% 1999
2021
Q4
$25M Sell
3,753,737
-534,812
-12% -$4.35M ﹤0.01% 1721
2021
Q3
$42.8M Sell
4,288,549
-399,419
-9% -$9.85M ﹤0.01% 1482
2021
Q2
$145M Sell
4,687,968
-137,591
-3% -$4.41M 0.01% 952
2021
Q1
$209M Buy
4,825,559
+1,384,255
+40% +$65.5M 0.02% 771
2020
Q4
$156M Buy
+3,441,304
New +$115M 0.01% 853

Other funds holding SPRY